Proteome Sciences plc

$0.02+0.00%(+$0.00)
TickerSpark Score
46/100
Weak
100
Valuation
40
Profitability
35
Growth
24
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMSNF research report →

52-Week Range14% of range
Low $0.01
Current $0.02
High $0.08

Companywww.proteomics.com

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers.

CEO
Christopher Donovan James Pearce
IPO
2010
Employees
36
HQ
Cobham, GB

Price Chart

-60.00% · this period
$0.05$0.03$0.01May 16Nov 14May 18

Valuation

Market Cap
$5.78M
P/E
-1.45
P/S
1.15
P/B
-0.46
EV/EBITDA
-11.11
Div Yield
0.00%

Profitability

Gross Margin
-26.81%
Op Margin
-70.98%
Net Margin
-81.50%
ROE
33.80%
ROIC
-34.27%

Growth & Income

Revenue
$3.76M · -23.16%
Net Income
$-3,060,503 · 10.14%
EPS
$-0.01 · 9.57%
Op Income
$-2,665,567
FCF YoY
86.38%

Performance & Tape

52W High
$0.08
52W Low
$0.01
50D MA
$0.04
200D MA
$0.04
Beta
0.22
Avg Volume
49

Get TickerSpark's AI analysis on PMSNF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our PMSNF Coverage

We haven't published any research on PMSNF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PMSNF Report →

Similar Companies